Loading stock analysis…
Evidence Synthesis
Last synthesized: 8 Jul 2026, 14:51
Evidence Synthesis
Gland (GLAND) experienced a significant shift in its quarterly financials, with the company's gross margin accelerating to 61.97%, up from 23.2%.
The company's marginal operating leverage also accelerated to , up from . Revenue growth slowed down, with the year-over-year growth rate decelerating to , down from 96.4%. The company's close price decreased to , down from 2550 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 61.97 % | 23.2 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 23.2 % | 15.98 | ▲ |
| REVENUE_GROWTH_YOY | 22.3 % | 96.4 | ▼ |
| EPS_ACTUAL | 13.327 INR | 11.15 | ▲ |
| EPS_SURPRISE_PERCENT | 0.004 % | -0.14 | ▲ |
| PRICE_CHANGE_PERCENT | -0.188 % | — | - |
| DAILY_VOLUME | 5,12,267 shares | 6,21,340 | ▼ |
| CLOSE_PRICE | 2,545.2 INR | 2,550 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.5 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 3 count | 7 | ▼ |
| TARGET_PRICE_PREMIUM | -13.98 % | — | - |